Navigation Links
UGA vet school receives $1.18 million NIH grant for rabies vaccine investigations
Date:10/4/2007

The National Institute of Allergy and Infectious Diseases at the National Institutes of Health has awarded the University of Georgia College of Veterinary Medicine a $1.18 million grant to develop rabies virus vaccines. This award is the continuation of a previous four-year $837,000 grant issued by NIAID in 2002 to initiate the study.

Zhen Fu, professor of veterinary pathology at UGA, is the principal investigator of the study, along with Ralph Tripp, GRA Eminent Scholar and professor of infectious diseases at the College of Veterinary Medicine, who will investigate the immunological aspects. Fus study is seeking a less expensive and less invasive means of vaccinating humans and animals. The proposed vaccine will use a genetically modified form of the live virus; one that will be potent enough to establish immunity with fewer doses, yet is very safe because the genetic modification makes the virus unable to cause the disease.

Current rabies vaccines are made from an inactivated (killed) virus, explained Fu. Although they are effective, multiple vaccines are needed to induce protective immunity. Todays vaccines also are very expensive and require five doses for people bitten by rabid animals or animals suspected of being rabid, making it cost prohibitive for people in developing countries where rabies vaccines are needed the most.

According to the World Health Organization, approximately 55,000 human deaths, primarily in Asia and Africa, are attributed annually to rabies. As a zoonotic viral disease that attacks the central nervous system, rabies infects both domestic and wild animals. It may be transmitted through bites or, less commonly, through close contact with saliva of infected animals on open areas such as skin scratches.

We propose to develop a live form of the vaccine by incorporation of immune stimulatory molecules into the virus genome, said Fu. By doing so, we expect to develop a vaccine with greater potency yet reduced cost, because fewer doses will be required to establish immunity. These vaccines can also be used in domestic as well as wild animals to protect them from rabies infection.

This could potentially save millions of dollars worldwide. According to the Centers for Disease Control, the estimated public health costs associated with disease detection, prevention, and control have risen to more than $300 million annually. These costs include the vaccination of companion animals, animal control programs, maintenance of rabies laboratories, and medical costs, such as those incurred for rabies post-exposure prophylaxis. Although the cost varies, a course of rabies immune globulin and five doses of vaccine given over a four-week period typically exceeds $1,000.

The College of Veterinary Medicine is dedicated to improving the health of animals and humans, said Dean Sheila W. Allen. That the National Institutes of Health has awarded another substantial grant for the study of rabies demonstrates their continued confidence in our researchers to find treatments and cures for diseases that affect both animals and people.


'/>"/>

Contact: Tracy Giese
tgiese@uga.edu
706-583-5485
University of Georgia
Source:Eurekalert

Related medicine news :

1. School Children Put To Risk Due To Shortage Of Nurses
2. Schools and Bars closed in Rwanda due to Cholera outbreak
3. Does Success in School Differ From the Real World Success ?
4. Preschoolers eat more when served in bigger helpings
5. Watching TV in the bedroom can lower children’s school performanc
6. Exposure to Pesticides in Schools Produces Illnesses Among Employees, Students
7. Adolescents Who Walk To School Are Fitter, More Active
8. Safe Neighborhood Means Less TV For Preschool Children
9. Popularity Among Peers Increases Susceptibility To Smoking Habit Among School Children
10. Vitamin filled nutrition candy for School children
11. Fish Oil supplementation reduces physical aggression in school children’
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 19, 2017 , ... Connecticut Dermatology Group (CDG) is proud and excited to ... dermatologist. Dr. Kim brings an extensive background in cutting-edge dermatology care and research ... to welcome back Dr. Kim to the CDG team” said President and Managing Partner ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Infinity® Massage Chairs ... plan and implement new sales and marketing strategies. Grover comes with a total of ... 5 and a half years as Executive Vice President of Direct Sales at Traeger® ...
(Date:1/18/2017)... ... January 18, 2017 , ... A recent video posting of a ... about the benefits of fidgeting to relieve stress and anxiety. No one was ... Think Ink Pen had just completed a successful Kickstarter campaign raising $67,000 on the ...
(Date:1/18/2017)... ... January 18, 2017 , ... The VA Maryland Health ... on a research project focused on multiple sclerosis (MS). Led by Christopher M. ... to control the disease without compromising normal immune function that often occurs during ...
(Date:1/18/2017)... FL (PRWEB) , ... January 18, 2017 , ... A ... fund raiser for Smile Train, an international charity that provides free surgery to poor ... of mine and in the past I have run to support the efforts of ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 18, 2017   Synthetic Biologics, ... company developing therapeutics designed to preserve the microbiome ... today confirmed plans to initiate a Phase 2b/3 ... reformulation of lovastatin lactone designed to reduce methane ... in the gut to treat the underlying cause ...
(Date:1/18/2017)... 18, 2017  Aprima Medical Software, a leading ... management (PM) and revenue cycle management (RCM) solutions ... a former reseller Healthcare Data Solutions (HDS) of ... Aprima will assume full support for HDS,s customers, ... practices across 15 states. Financial terms were not ...
(Date:1/18/2017)... 18, 2017   Spotlight Innovation Inc. ... plans, in the second quarter of 2017, to ... intended to provide relief from chronic pain, is ... It was developed under a licensing agreement with ... derived from snake venom. Additionally, Caretta Therapeutics has ...
Breaking Medicine Technology: